The popular heartburn medication Zantac has been linked to a higher risk of multiple cancers, including
- Bladder Cancer
- Breast Cancer
- Colorectal (Colon) Cancer
- Esophageal Cancer
- Stomach Cancer
- Intestinal Cancer
- Kidney Cancer
- Liver Cancer
- Lung Cancer
- Pancreatic Cancer
- Prostate Cancer
Zantac was used by millions of people from the 1980s to 2020 as a treatment for heartburn, acid reflux, and gastroesophageal reflux disease (GERD). However, researchers found that its active ingredient, ranitidine, could become contaminated with the powerful carcinogen NDMA. What’s more, ranitidine tends to become more contaminated while being stored or even while being metabolized, putting people at even greater risk of NDMA exposure.
Many Zantac lawsuits allege that the drug’s manufacturer knew about the risks of NDMA contamination and failed to properly warn the public or medical community of these risks. If you’ve developed one or more of the above forms of cancer after using Zantac to treat chronic heartburn, you could be entitled to compensation. Call the defective drug lawyers at Gordon McKernan Injury Attorneys for a free legal consultation.
INJURED?
GET HELP NOW!
